Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(30 sites) United States
University Of Alabama, Birmingham, Alabama Childrens National Hospital, Washington D.C., District of Columbia University of Florida, Jacksonville, Florida Augusta University Georgia, Augusta, Georgia WCG Sonar Clinical Research, Riverdale, Georgia Norton Children s Hospital, Louisville, Kentucky The Johns Hopkins University School of Medicine, Baltimore, Maryland Southern Specialty Research, Flowood, Mississippi Childrens Hospital at Montefiore, The Bronx, New York East Carolina University, Greenville, North Carolina Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina Spoknwrdclinicaltrials, Easton, Pennsylvania U of TX Health Science Ct, Houston, Texas Brazil
Novartis Investigative Site, Salvador, Estado de Bahia Novartis Investigative Site, São Luís, Maranhão Novartis Investigative Site, Campinas, São Paulo Novartis Investigative Site, Ribeirão Preto, São Paulo Novartis Investigative Site, Sao Jose Rio Preto, São Paulo Novartis Investigative Site, São Paulo, São Paulo Novartis Investigative Site, São Paulo, São Paulo Colombia
Novartis Investigative Site, Medellín, Antioquia Novartis Investigative Site, Cali, Valle del Cauca Department Novartis Investigative Site, Cali, Valle del Cauca Department Novartis Investigative Site, Montería Kenya
Novartis Investigative Site, Ahero, Kisumu County Novartis Investigative Site, Kisumu Novartis Investigative Site, Kisumu Novartis Investigative Site, Siaya Uganda
Novartis Investigative Site, Kampala Novartis Investigative Site, Tororo